Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cimetidine
Cat. No.:
OB0225LY-0178
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Cimetidine is a histamine H2 receptor antagonist used primarily in gastrointestinal-related studies to reduce gastric acid secretion.
Synonym:
SKF-92334; 51481-61-9; Cimal; Cimetag; Cimetum; 1-Cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine
CAS No.:
51481-61-9
Compound CID:
2756
Formula:
C10H16N6S
Formula Weight:
252.34
Specification
Relative Density:
1.2583 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cimetidine can be used to study the mechanism of gastric acid secretion or play an important role in the study of digestive system diseases.
Library Information
Targets:
Histamine receptor family
Receptors:
H2 receptor
Pathways:
Neuronal signaling; GPCR/G protein; Immunology/Inflammation
Plate Number:
AOCL-3
Plate Location:
b11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 178.33 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
3 mg/mL; 11.89 mM
